Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma.

Chin Med J (Engl) · 2023 · PMC10344481 · PMID 37306432

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In subgroup analyses, the R2-ISS model adequately predicted the OS rates in most patients except those receiving ASCT, but the survival curve depicting the OS in ASCT group showed a trend consistent with other subgroups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.